Slaughter and May advised Union Medical Healthcare Limited – Global Offering and Listing on the Main Board of the Hong Kong Stock Exchange

Slaughter and May, Hong Kong, advised on the global offering and listing of Union Medical Healthcare Limited (UMH) on the Main Board of the Hong Kong Stock Exchange. The global offering consisted of a Hong Kong public offering and a concurrent Rule 144A/Regulation S placement and raised approximately HK$706 million (before the exercise of the over-allotment option). Slaughter and May advised the underwriters, including Credit Suisse (Hong Kong) Limited, Haitong International Securities Company Limited and CIMB Securities Limited as to U.S. and Hong Kong laws on the global offering.

UMH is an aesthetic medical service provider that focuses on providing aesthetic surgical procedures, minimally invasive procedures and energy-based procedures in Hong Kong and Greater China and owns the brand DR REBORN. UMH was ranked first in Hong Kong in terms of the number of aesthetic injection procedures performed involving utilisation of the top-six revenue-generating aesthetic medications in Hong Kong and in terms of the number of breast augmentation, liposuction and double-eyelid surgery procedures performed for each of 2012, 2013 and 2014.

Dealings in the shares of UMH on the Hong Kong Stock Exchange commenced on 11 March 2016.

Benita Yu Senior Partner
John Moore Partner
Jianhao Zheng Counsel
Vincent Chan Partner